cIAP2 has previously been associated with drug resistance in pancreatic cancer, colorectal cancer (220, 221), and oral squamous cell carcinoma (222, 223), further supporting its role in mediating chemoresistance. This evidence concerns the gene BIRC3 and colorectal cancer.